RIPPLY2

RIPPLY2 is a transcriptional co-repressor essential for vertebrate somitogenesis, acting at the anterior presomitic mesoderm to define segmentation boundaries and establish rostrocaudal somite polarity. It physically binds Tbx6 and recruits the Groucho/TLE co-repressor complex to convert Tbx6 from a transcriptional activator to a repressor, while simultaneously recruiting the proteasome to drive Tbx6 protein degradation—a post-translational mechanism that is independent of Mesp2 and sufficient to phenocopy the Tbx6-null state (PMID:18332117, PMID:29761784, PMID:25641698). RIPPLY2 itself is a direct transcriptional target of Mesp2 and is spatially restricted by Wnt3a/β-catenin, FGF, and retinoic acid signaling, creating a negative-feedback loop in which Ripply2 suppresses its own upstream activators and terminates clock gene oscillations to convert dynamic signals into stable somite boundaries (PMID:17360776, PMID:18045842, PMID:37055428). Loss-of-function mutations in RIPPLY2 cause autosomal recessive Klippel-Feil syndrome with heterotaxy in humans (PMID:26238661).

1. 2007 High

   Establishing that Ripply2 is essential for somitogenesis: knockout mice revealed segmentation and rostrocaudal polarity defects, and Ripply2 was identified as a direct Mesp2 target participating in a negative-feedback loop.

   Evidence Ripply2 knockout mouse with skeletal analysis, microarray, ChIP/enhancer assays, in situ hybridization across two independent studies

   PMID:17360776 PMID:17531978

   Open questions at the time

   • Molecular mechanism of Ripply2 repressive activity unknown at this stage
   • Relationship between Ripply2 and Tbx6 protein not yet defined
2. 2007 High

   Upstream signaling control was clarified: Wnt3a/β-catenin restricts Ripply2 expression to the anterior PSM by repressing it posteriorly and activating it anteriorly, embedding Ripply2 in the segmentation signaling network.

   Evidence Conditional Ctnnb1 alleles and Wnt3a−/− embryos with in situ hybridization

   PMID:17937396 PMID:18045842

   Open questions at the time

   • Whether FGF or RA signaling also regulates Ripply2 was not yet tested
   • Mechanism by which β-catenin switches from repressor to activator at different PSM positions unresolved
3. 2008 High

   The molecular mechanism of Ripply-mediated repression was defined: Ripply proteins physically associate with T-box factors (including Tbx6) and recruit Groucho/TLE co-repressors, converting T-box factors from activators to repressors.

   Evidence Co-immunoprecipitation, transcriptional reporter assays, dominant-negative mutagenesis in zebrafish

   PMID:18332117

   Open questions at the time

   • Whether Ripply2 also promotes Tbx6 protein degradation was not known
   • Structural basis of Ripply–T-box interaction undefined
4. 2010 High

   Functional redundancy between Ripply1 and Ripply2 was established: double-knockout mice showed anterior expansion of the Tbx6 protein domain and loss of Notch activity, demonstrating that both paralogs jointly regulate the Tbx6 boundary.

   Evidence Ripply1/2 double-knockout mouse, Tbx6 and Mesp2 immunostaining, Notch activity reporter

   PMID:20346937

   Open questions at the time

   • Whether Ripply1 and Ripply2 act through identical or distinct biochemical mechanisms not resolved
   • Contribution of each paralog to Tbx6 protein clearance vs. transcriptional repression not separated
5. 2015 High

   Ripply2 was shown to act post-translationally on Tbx6—eliminating Tbx6 protein without affecting its mRNA—independent of Mesp2, and ectopic Ripply2 expression throughout the PSM phenocopied the Tbx6-null state.

   Evidence Multiple transgenic mouse models with Ripply2 overexpression/knockin, immunostaining for Tbx6 protein vs. mRNA

   PMID:25641698

   Open questions at the time

   • Proteasomal vs. lysosomal degradation pathway not yet distinguished
   • Whether ubiquitination is required for Ripply2-mediated Tbx6 clearance unknown
6. 2018 High

   The degradation mechanism was elucidated: Ripply2 directly recruits proteasome complexes to Tbx6 for degradation, as identified by mass spectrometry, and a T-box motif in Tbx6 is required for this process independently of the Ripply2–Tbx6 binding interface.

   Evidence Co-immunoprecipitation, mass spectrometry of Ripply2-associated proteins in PSM-fated ES cells, T-box motif mutagenesis in vivo

   PMID:29761784

   Open questions at the time

   • Whether Ripply2 itself is an E3 ligase adapter or relies on an intermediary ubiquitin ligase is unresolved
   • No structural model of the Ripply2–Tbx6–proteasome complex exists
7. 2018 Medium

   The target range of Ripply2 was expanded beyond Tbx6: Ripply2 represses the Hes7 essential region in the anterior PSM, acting alongside Tbx18 and Hes7 autorepression to restrict clock gene expression.

   Evidence Luciferase reporter assays, in vitro binding assays, transgenic mice

   PMID:29895619

   Open questions at the time

   • Whether Ripply2 acts on Hes7 via Tbx6 degradation or through an independent mechanism not fully distinguished
   • No genome-wide identification of Ripply2 target loci performed
8. 2015 Medium

   RIPPLY2 was linked to human disease: a homozygous frameshift mutation in RIPPLY2 causes autosomal recessive Klippel-Feil syndrome with heterotaxy, consistent with its role in somite segmentation.

   Evidence Exome sequencing with familial segregation analysis

   PMID:26238661

   Open questions at the time

   • No in vitro functional validation of the specific frameshift mutation was performed in this study
   • Mechanism linking Ripply2 loss to laterality defects (heterotaxy) not elucidated
9. 2023 High

   Ripply-mediated Tbx6 removal was integrated into a systems-level model: Ripply expression is periodically regulated by clock oscillation and Erk signaling, and sustained Tbx6 suppression by Ripply is the key event converting dynamic oscillations into stable somite boundaries.

   Evidence Zebrafish genetics, live imaging, chemical inhibition, mathematical modeling

   PMID:37055428

   Open questions at the time

   • Whether mammalian Ripply2 is similarly periodically regulated by Erk remains to be tested in mouse
   • How Ripply degradation dynamics are controlled after each cycle is not defined

• Key open questions include the structural basis of the Ripply2–Tbx6 interaction, whether Ripply2 acts as a direct ubiquitin ligase adapter, the full genome-wide set of Ripply2 transcriptional targets, and the mechanistic link between RIPPLY2 loss and laterality defects in humans.
• No crystal or cryo-EM structure of Ripply2 or its complexes exists
• Ubiquitination pathway connecting Ripply2 to proteasomal Tbx6 degradation not identified
• Genome-wide ChIP-seq or CUT&RUN for Ripply2 not performed